General information about company
Scrip code*		500412
NSE Symbol*		TIRUMALCHM
MSEI Symbol*		NOTLISTED
ISIN*		INE338A01024
Name of company		Thirumalai Chemicals Limited
Type of company		Main Board
Class of security		Equity
Date of start of financial year		01-04-2025
Date of end of financial year		31-03-2026
Date of board meeting when results were approved		08-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange		04-11-2025
Description of presentation currency		INR
Level of rounding		Lakhs
Reporting Type		Quarterly
Reporting Quarter		Second quarter
Nature of report standalone or consolidated		Standalone
Whether results are audited or unaudited for the quarter ended		Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended		Unaudited
Segment Reporting		Single segment
Description of single segment		Chemical products and its intermediaries
Start date and time of board meeting		08-11-2025 10:30
End date and time of board meeting		08-11-2025 14:20
Whether cash flow statement is applicable on company		Yes
Type of cash flow statement		Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification		Not applicable
Whether the company has any related party?		Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?		Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public		NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.		NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?		No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?		Yes
Latest Date on which RPT policy is updated		08-11-2025
Indicate Company website link for updated RPT policy of the Company		https://thirumalaichemicals.com/compliance-policies/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?		Yes
No. of times funds raised during the quarter		1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No	Not Applicable

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-07-2025	01-04-2025
Date of end of reporting period		30-09-2025	30-09-2025
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	35701	80251
	Other income	1486	1796
	Total income	37187	82047
2	Expenses
(a)	Cost of materials consumed	24789	56886
(b)	Purchases of stock-in-trade	6019	12619
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-1919	-2481
(d)	Employee benefit expense	1557	2760
(e)	Finance costs	2021	3659
(f)	Depreciation, depletion and amortisation expense	870	1730
(g)	Other Expenses
1	Other Expenses	5602	10444
	Total other expenses	5602	10444
	Total expenses	38939	85617
3	Total profit before exceptional items and tax	-1752	-3570
4	Exceptional items	0	0
5	Total profit before tax	-1752	-3570
6	Tax expense
7	Current tax	0	0
8	Deferred tax	-420	-855
9	Total tax expenses	-420	-855
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	-1332	-2715
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	-1332	-2715
17	Other comprehensive income net of taxes	-1411	-245
18	Total Comprehensive Income for the period	-2743	-2960
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	1187	1187
	Face value of equity share capital	1	1
22	Reserves excluding revaluation reserve
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-1.22	-2.57
	Diluted earnings (loss) per share from continuing operations	-1.22	-2.57
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
iii	Earnings per equity share (for continuing and discontinued operations)
	Basic earnings (loss) per share from continuing and discontinued operations	-1.22	-2.57
	Diluted earnings (loss) per share from continuing and discontinued operations	-1.22	-2.57
24	Debt equity ratio			Textual Information( 1)
25	Debt service coverage ratio			Textual Information( 2)
26	Interest service coverage ratio			Textual Information( 3)
27	Disclosure of notes on financial results	Textual Information(4)

Statement of Asset and Liabilities
Particulars		Half Year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2025
Date of end of reporting period		30-09-2025
Whether results are audited or unaudited		Unaudited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	35887
	Capital work-in-progress	1076
	Investment property
	Goodwill	0
	Other intangible assets	1674
	Intangible assets under development
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	151350
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	280
	Total non-current financial assets	151630
	Deferred tax assets (net)	669
	Other non-current assets	81
	Total non-current assets	191017
2	Current assets
	Inventories	24070
	Current financial asset
	Current investments	0
	Trade receivables, current	31004
	Cash and cash equivalents	4003
	Bank balance other than cash and cash equivalents	407
	Loans, current	5816
	Other current financial assets	6038
	Total current financial assets	47268
	Current tax assets (net)	0
	Other current assets	3390
	Total current assets	74728
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	265745
	Total current assets	74728
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	265745
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	1187
	Other equity	150457
	Total equity attributable to owners of parent	151644
	Non controlling interest
	Total equity	151644
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	51969
	Trade Payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	95
	Total non-current financial liabilities	52064
	Provisions, non-current	1353
	Deferred tax liabilities (net)	5099
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	58516
	Current liabilities
	Current financial liabilities
	Borrowings, current	23072
	Trade Payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	450
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	29441
	Total Trade payable	29891
	Other current financial liabilities	1484
	Total current financial liabilities	54447
	Other current liabilities	600
	Provisions, current	538
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	55585
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	114101
	Total equity and liabilities	265745
	Disclosure of notes on assets and liabilities	Textual Information(1)

Other Comprehensive Income
Date of start of reporting period		01-07-2025	01-04-2025
Date of end of reporting period		30-09-2025	30-09-2025
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurements of defined benefit plans	-72.00	-70.00
2	Equity instruments through other comprehensive income	-1591.00	-225.00
3	Income tax relating to items that will not be reclassified to profit or loss	252.00	50.00
	Total Amount of items that will not be reclassified to profit and loss	-1411.00	-245.00
2	Income tax relating to items that will not be reclassified to profit or loss	0.00	0.00
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0.00	0.00
5	Total Other comprehensive income	-1411.00	-245.00

Cash flow statement, indirect
Particulars		Half Year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2025
Date of end of reporting period		30-09-2025
Whether results are audited or unaudited		Unaudited
Nature of report standalone or consolidated		Standalone
Part I	Blue color marked fields are non-mandatory.
1	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	-3570
2	Adjustments for reconcile profit (loss)
	Adjustments for finance costs	3659
	Adjustments for decrease (increase) in inventories	-7747
	Adjustments for decrease (increase) in trade receivables, current	-7525
	Adjustments for decrease (increase) in trade receivables, non-current	0
	Adjustments for decrease (increase) in other current assets	-708
	Adjustments for decrease (increase) in other non-current assets	44
	Adjustments for other financial assets, non-current	82
	Adjustments for other financial assets, current	-1332
	Adjustments for other bank balances	0
	Adjustments for increase (decrease) in trade payables, current	-11774
	Adjustments for increase (decrease) in trade payables, non-current	0
	Adjustments for increase (decrease) in other current liabilities	-105
	Adjustments for increase (decrease) in other non-current liabilities	0
	Adjustments for depreciation and amortisation expense	1730
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss	0
	Adjustments for provisions, current	0
	Adjustments for provisions, non-current	0
	Adjustments for other financial liabilities, current	-579
	Adjustments for other financial liabilities, non-current	0
	Adjustments for unrealised foreign exchange losses gains	0
	Adjustments for dividend income	227
	Adjustments for interest income	322
	Adjustments for share-based payments	0
	Adjustments for fair value losses (gains)	0
	Adjustments for undistributed profits of associates	0
	Other adjustments for which cash effects are investing or financing cash flow	0
	Other adjustments to reconcile profit (loss)	0
	Other adjustments for non-cash items	-213
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships	0
	Total adjustments for reconcile profit (loss)	-25017
	Net cash flows from (used in) operations	-28587
	Dividends received	0
	Interest paid	0
	Interest received	0
	Income taxes paid (refund)	166
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) operating activities	-28753
3	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses	0
	Cash flows used in obtaining control of subsidiaries or other businesses	0
	Other cash receipts from sales of equity or debt instruments of other entities	0
	Other cash payments to acquire equity or debt instruments of other entities	36481
	Other cash receipts from sales of interests in joint ventures	0
	Other cash payments to acquire interests in joint ventures	0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships	0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships	0
	Proceeds from sales of property, plant and equipment	0
	Purchase of property, plant and equipment	0
	Proceeds from sales of investment property	0
	Purchase of investment property	0
	Proceeds from sales of intangible assets	0
	Purchase of intangible assets	0
	Proceeds from sales of intangible assets under development	0
	Purchase of intangible assets under development	0
	Proceeds from sales of goodwill	0
	Purchase of goodwill	0
	Proceeds from biological assets other than bearer plants	0
	Purchase of biological assets other than bearer plants	0
	Proceeds from government grants	0
	Proceeds from sales of other long-term assets	0
	Purchase of other long-term assets	0
	Cash advances and loans made to other parties	0
	Cash receipts from repayment of advances and loans made to other parties	0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts	0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts	0
	Dividends received	227
	Interest received	42
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	-1609
	Net cash flows from (used in) investing activities	-37821
4	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries	0
	Payments from changes in ownership interests in subsidiaries	0
	Proceeds from issuing shares	45062
	Proceeds from issuing other equity instruments	0
	Payments to acquire or redeem entity's shares	0
	Payments of other equity instruments	0
	Proceeds from exercise of stock options	0
	Proceeds from issuing debentures notes bonds etc	0
	Proceeds from borrowings	64796
	Repayments of borrowings	42724
	Payments of lease liabilities	186
	Dividends paid	0
	Interest paid	3087
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) financing activities	63861
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	-2713
5	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents	340
	Net increase (decrease) in cash and cash equivalents	-2373
	Cash and cash equivalents cash flow statement at beginning of period	6376
	Cash and cash equivalents cash flow statement at end of period	4003

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.

Sr. No.

Details of the party (listed entity /subsidiary) entering into the transaction

Details of the counterparty

Type of related party transaction

Details of other related party transaction

Value of the related party transaction as approved by the audit committee

Remarks on approval by audit committee

Value of the related party transaction ratified by the audit committee

Date of Audit Committee Meeting where the ratification was approved

Value of transaction during the reporting period

In case monies are due to either party as a result of the transaction

In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments

Details of the loans, inter-corporate deposits, advances or investments

Name

PAN

Name

PAN

Relationship of the counterparty with the listed entity or its subsidiary

Opening balance

Closing balance

Nature of indebtedness (loan/ issuance of debt/ any other etc.)

Details of other indebtedness

Cost

Tenure

Nature (loan/ advance/ intercorporate deposit/ investment)

Interest Rate (%)

Tenure

Secured/ unsecured

Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)

Notes

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mr. R.Parthasarathy

AAHPP7475K

Remuneration

Nil

205.41

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mrs. Ramya Bharathram

AGDPB4141J

MD & CFO

Remuneration

Nil

101.49

THIRUMALAI CHEMICALS LTD

AAACT2015M

MR. C.G Sethuram

AALPS5433Q

Group Chief Executive Officer

Remuneration

Nil

154.18

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mr.Sanjay Sinha

AAMPS2498C

Chief Executive Officer

Remuneration

Nil

93.38

THIRUMALAI CHEMICALS LTD

AAACT2015M

MR. Pramodkumar R

AMIPP1268K

Company Secretary

Remuneration

Nil

5.2

THIRUMALAI CHEMICALS LTD

AAACT2015M

MR. Aditya Sharma

BNHPS3253G

Company Secretary

Remuneration

Nil

3.18

THIRUMALAI CHEMICALS LTD

AAACT2015M

Ultramarine and Pigments Limited

AAACU0718Q

Promoters Group

Purchase of goods or services

Yes

12.84

1.08

1.89

THIRUMALAI CHEMICALS LTD

AAACT2015M

Ultramarine and Pigments Limited

AAACU0718Q

Promoters Group

Sale of goods or services

Yes

22.95

4.17

THIRUMALAI CHEMICALS LTD

AAACT2015M

Ultramarine and Pigments Limited

AAACU0718Q

Promoters Group

Any other transaction

Deposit payable

Nil

THIRUMALAI CHEMICALS LTD

AAACT2015M

Ultramarine and Pigments Limited

AAACU0718Q

Promoters Group

Any other transaction

Loan payable

Nil

2000

THIRUMALAI CHEMICALS LTD

AAACT2015M

Ultramarine and Pigments Limited

AAACU0718Q

Promoters Group

Any other transaction

Interest paid

175

Yes

92.75

THIRUMALAI CHEMICALS LTD

AAACT2015M

Ultramarine and Pigments Limited

AAACU0718Q

Promoters Group

Any other transaction

Investment to subsidiary

Nil

19931.88

19703.04

THIRUMALAI CHEMICALS LTD

AAACT2015M

Ultramarine and Pigments Limited

AAACU0718Q

Promoters Group

Any other transaction

Dividend Received

Nil

226.74

THIRUMALAI CHEMICALS LTD

AAACT2015M

Thirumalai Charity Trust

AAATT0087A

Other related party

Purchase of goods or services

Yes

1.59

0.04

0.34

THIRUMALAI CHEMICALS LTD

AAACT2015M

Thirumalai Charity Trust

AAATT0087A

Other related party

Any other transaction

CSR Donation

200

Yes

THIRUMALAI CHEMICALS LTD

AAACT2015M

TCL INTERMEDIATES PVT LTD

AAJCT0669G

Wholly owned subsidiary

Purchase of goods or services

310

Yes

71.55

7.45

88.73

THIRUMALAI CHEMICALS LTD

AAACT2015M

TCL INTERMEDIATES PVT LTD

AAJCT0669G

Wholly owned subsidiary

Sale of goods or services

17337.09

yes

13218.56

6164.11

18399.85

THIRUMALAI CHEMICALS LTD

AAACT2015M

TCL INTERMEDIATES PVT LTD

AAJCT0669G

Wholly owned subsidiary

Any other transaction

Loan to subsidiary

3800

yes

5400

THIRUMALAI CHEMICALS LTD

AAACT2015M

TCL INTERMEDIATES PVT LTD

AAJCT0669G

Wholly owned subsidiary

Any other transaction

Interest Received

943

yes

279.98

THIRUMALAI CHEMICALS LTD

AAACT2015M

TCL INTERMEDIATES PVT LTD

AAJCT0669G

Wholly owned subsidiary

Any other transaction

Investment in Subsidiary

Nil

23875.08

THIRUMALAI CHEMICALS LTD

AAACT2015M

OPTIMISTIC ORGANIC SDN BHD

ZZZZZ9999Z

Step Down Subsidiary

Purchase of goods or services

200

Yes

81.67

26.07

37.83

THIRUMALAI CHEMICALS LTD

AAACT2015M

OPTIMISTIC ORGANIC SDN BHD

ZZZZZ9999Z

Step Down Subsidiary

Sale of goods or services

101.5

Yes

15.77

131.3

105.32

THIRUMALAI CHEMICALS LTD

AAACT2015M

OPTIMISTIC ORGANIC SDN BHD

ZZZZZ9999Z

Step Down Subsidiary

Any other transaction

Investment to subsidiary

Nil

3082.83

THIRUMALAI CHEMICALS LTD

AAACT2015M

TCL GLOBAL BV

ZZZZZ9999Z

Wholly owned subsidiary

Purchase of goods or services

181.55

Yes

175.42

0.46

156.55

THIRUMALAI CHEMICALS LTD

AAACT2015M

TCL GLOBAL BV

ZZZZZ9999Z

Wholly owned subsidiary

Sale of goods or services

5000

Yes

1681.17

723.45

608.3

THIRUMALAI CHEMICALS LTD

AAACT2015M

TCL GLOBAL BV

ZZZZZ9999Z

Wholly owned subsidiary

Any other transaction

Investment to subsidiary

Nil

61215.93

97697.09

THIRUMALAI CHEMICALS LTD

AAACT2015M

TCL SPECIALTIES LLC

ZZZZZ9999Z

Step Down Subsidiary

Sale of goods or services

57000

Yes

29692.93

-29574.06

-4200.27

THIRUMALAI CHEMICALS LTD

AAACT2015M

TCL SPECIALTIES LLC

ZZZZZ9999Z

Step Down Subsidiary

Any other transaction

Investment to subsidiary

Nil

1531.55

THIRUMALAI CHEMICALS LTD

AAACT2015M

Cheminvest Pte Ltd

ZZZZZ9999Z

Wholly owned subsidiary

Any other transaction

Investment to subsidiary

Nil

5428.31

THIRUMALAI CHEMICALS LTD

AAACT2015M

Jasmine Ltd

ZZZZZ9999Z

Promoters Group

Any other transaction

Investment to subsidiary

Nil

67.72

THIRUMALAI CHEMICALS LTD

AAACT2015M

ICE Steel 1 Pvt Ltd

AACCD7385E

Other related party

Purchase of goods or services

Nil

2.82

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mr. Raj Kataria

AAPPK0522Q

Other related party

Any other transaction

Sitting fees paid

Nil

3.3

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mr. Arun Ramanathan

ABMPR1919A

Other related party

Any other transaction

Sitting fees paid

Nil

3.6

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mr. Rajeev M. Pandia

AAEPP3004D

Other related party

Any other transaction

Sitting fees paid

Nil

10.95

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mrs. Bhama Krishnamurthy

AAPPK0269A

Other related party

Any other transaction

Sitting fees paid

Nil

7.5

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mr. Dhruv Moondhra

AGQPM2062C

Other related party

Any other transaction

Sitting fees paid

Nil

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mr. Arun Alagappan

AACPA9627P

Other related party

Any other transaction

Sitting fees paid

Nil

1.8

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mr R Sampath

AALPS9616D

Promoters Group

Any other transaction

Sitting fees paid

Nil

6.15

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mr. M Somasundaram

AAXPS0381F

Other related party

Any other transaction

Sitting fees paid

Nil

10.35

THIRUMALAI CHEMICALS LTD

AAACT2015M

Ms.Sabitha

AAZPS2302N

Other related party

Any other transaction

Sitting fees paid

Nil

THIRUMALAI CHEMICALS LTD

AAACT2015M

Mr.Meghav Deepak Mehta

AKLPM5611J

Other related party

Any other transaction

Sitting fees paid

NIl

1.5

Total value of transaction during the reporting period

46324.91

Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Mode of Fund Raising	Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	26-08-2025
Amount Raised	45062.47
Report filed for Quarter ended	30-09-2025
Monitoring Agency	Applicable
Monitoring Agency Name, if applicable	CRISIL Limited
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation	Not Applicable
Comments of the Audit Committee after review	Nil
Comments of the auditors, if any	Nil

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Investment in TCL global BV for onward investment eventually into TCL Specialties LLC in the United States of America to finance capital expenditure	Nil	33000	0	32752.85	0
2	General Corporate Purposes	Nil	11062.47	0	9910.56	0
3	Issue Expenses	Nil	1000	0	0	0

Signatory Details
Name of signatory	Ramya Bharathram
Designation of person	Managing Director
Place	Chennai
Date	08-11-2025

General information about company

Financial Results – Ind-AS

Statement of Asset and Liabilities

Other Comprehensive Income

Cash flow statement, indirect

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Signatory Details